Veterinary medicines in 2024
25 new medicines recommended for approval; two with a new active substance
NewsVeterinaryMedicines
EMA has published an overview of its key recommendations of 2024 regarding the authorisation and safety monitoring of veterinary medicines.
In 2024, EMA recommended 25 veterinary medicines for marketing authorisation – the highest ever number of recommendations in a year. Of these, two had a new active substance which had not previously been authorised in a veterinary medicine in the EU. 14 were vaccines, including seven that had been developed by means of a biotechnological process.
Among the medicines recommended for marketing authorisation in 2024, 13 were for food-producing animals, such as chickens, pigs and cattle, and 11 were for companion animals, such as dogs and cats.
A selection of these recommendations can be found in the veterinary medicines highlights document published today.